Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Linecker, Michael; Björnsson, Bergthor; Stavrou, Gregor A; Oldhafer, Karl J; Lurje, Georg; Neumann, Ulf; Adam, René; Pruvot, Francois-René; Topp, Stefan A; Li, Jun; Capobianco, Ivan; Nadalin, Silvio; Machado, Marcel Autran; Voskanyan, Sergey; Balci, Deniz; Hernandez-Alejandro, Roberto; Alvarez, Fernando A; De Santibañes, Eduardo; Robles-Campos, Ricardo; Malagó, Massimo; de Oliveira, Michelle L; Lesurtel, Mickael; Clavien, Pierre-Alain; Petrowsky, Henrik (2017). Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity. Annals of Surgery, 266(5):779-786.

Linecker, Michael; Stavrou, Gregor A; Oldhafer, Karl J; Jenner, Robert M; Seifert, Burkhardt; Lurje, Georg; Bednarsch, Jan; Neumann, Ulf; Capobianco, Ivan; Nadalin, Silvio; Robles-Campos, Ricardo; de Santibañes, Eduardo; Malagó, Massimo; Lesurtel, Mickael; Clavien, Pierre-Alain; Petrowsky, Henrik (2016). The ALPPS risk score: Avoiding futile use of ALPPS. Annals of Surgery, 264(5):763-771.

Sommerer, Claudia; Budde, Klemens; Zeier, Martin; Wüthrich, Rudolf P; Reinke, Petra; Eisenberger, Ute; Mühlfeld, Anja; Arns, Wolfgang; Stahl, Rolf; Heller, Katharina; Wolters, Heiner H; Suwelack, Barbara; Klehr, Hans Ulrich; Hauser, Ingeborg A; Stangl, Manfred; Nadalin, Silvio; Dürr, Michael; Porstner, Martina; May, Christoph; Wimmer, Peter; Witzke, Oliver; Lehner, Frank (2016). Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial. Clinical Nephrology, 85(4):215-225.

Lehner, Frank; Budde, Klemens; Zeier, Martin; Wüthrich, Rudolf P; Reinke, Petra; Eisenberger, Ute; Mühlfeld, Anja; Arns, Wolfgang; Stahl, Rolf; Heller, Katharina; Witzke, Oliver; Wolters, Heiner H; Suwelack, Barbara; Klehr, Hans Ulrich; Stangl, Manfred; Hauser, Ingeborg A; Nadalin, Silvio; Porstner, Martina; May, Christoph; Paulus, Eva-Maria; Sommerer, Claudia (2014). Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study. Transplant International, 27(11):1192-204.

This list was generated on Fri May 25 20:30:56 2018 CEST.